# The Use of High Concentration Hyaluronic Acid (HA) Transfer Medium in Repeated Implantation Failure (RIF) Patients

> **NCT04709796** · NA · UNKNOWN · sponsor: **University Hospital, Ghent** · enrollment: 178 (estimated)

## Conditions studied

- IVF
- Embryo Loss
- Miscarriage, Recurrent

## Interventions

- **DRUG:** EmbryoGlue®, Vitrolife
- **DRUG:** Conventional Transfer

## Key facts

- **NCT ID:** NCT04709796
- **Lead sponsor:** University Hospital, Ghent
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-03-03
- **Primary completion:** 2024-12-31
- **Final completion:** 2025-06-30
- **Target enrollment:** 178 (ESTIMATED)
- **Last updated:** 2024-04-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04709796

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04709796, "The Use of High Concentration Hyaluronic Acid (HA) Transfer Medium in Repeated Implantation Failure (RIF) Patients". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT04709796. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*